GlobeNewswire Inc | Oct 18, 2021 06:30AM EDT

October 18, 2021

GAITHERSBURG, Md., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, November 4, 2021 at 5:00 pm eastern time to discuss the financial results for the third quarter of 2021, recent business developments, and financial outlook for full year 2021.

This conference call can be accessed live by telephone or by webcast:

eleconference InformationDial in number toll-free: (855) 766-6521Dial in number toll: (262) 912-6157Conference ID: 2937668

Webcast Information:Visit https://edge.media-server.com/mmc/p/nitqgk48 for the live webcast.

A replay of the call can be accessed from the Emergent website.

Investor Contact:About Emergent BioSolutionsEmergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Through our specialty products and contract development and manufacturing services, we are dedicated to providing solutions that address public health threats. Through social responsibility, we aim to build healthier and safer communities. We aspire to deliver peace of mind to our patients and customers so they can focus on whats most important in their lives. In working together, we envision protecting or enhancing 1 billion lives by 2030. For more information, visit our website and follow us on LinkedIn, Twitter, and Instagram.

Robert G. BurrowsVice President, Investor Relationsburrowsr@ebsi.com

Media Contact:Matt HartwigSenior Director, Media Relationshartwigm@ebsi.com